<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-SLB-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Salomon (les &#xCE;les): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Solomon Islands: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-44001" role="4" type="40">
   <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
  </participating-org>
  <participating-org ref="US-EIN-91-1157127" role="4">
   <narrative xml:lang="EN">PATH</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Solomon Islands</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="SB" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="SB" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Honiara</narrative>
   </name>
   <administrative code="SB" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-9.43333 159.95</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1668220</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1718621</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1182771</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">97901</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="SLBPEF-TCA-GFA2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">396109</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-IBRD2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-PATH2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">38266</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">11127</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">394200</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">628518</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-GFA2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">130153</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-IBRD2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-PATH2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">44199</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">30951</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">595080</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">718238</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-IBRD2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-PATH2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">106685</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">42626</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">339120</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">494340</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLBPEF-TCA-PATH2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">97901</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001041">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">19382</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001065">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">25280</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001232">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-62406</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001208">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">43715</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001359">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-19421</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001339">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-24485</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900003850">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">68585</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006994">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">79636</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000197">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-10-29"></transaction-date>
   <value currency="USD" value-date="2019-10-29">52122</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000982">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-17"></transaction-date>
   <value currency="USD" value-date="2019-12-17">38890</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">16762</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">56547</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">57564</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">8277</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-16762</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-56547</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-57564</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-8277</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000820">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-12"></transaction-date>
   <value currency="USD" value-date="2020-03-12">70140</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001158">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-07"></transaction-date>
   <value currency="USD" value-date="2020-04-07">42718</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001873">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-07"></transaction-date>
   <value currency="USD" value-date="2020-05-07">46972</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002743">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">48516</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001133">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001342">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-06"></transaction-date>
   <value currency="USD" value-date="2020-04-06">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002781">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-17"></transaction-date>
   <value currency="USD" value-date="2021-06-17">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">38266</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001178">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-14"></transaction-date>
   <value currency="USD" value-date="2020-05-14">25000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002734">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">13534</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005596">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">50534</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">9845</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-664</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">1040</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001193">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-29"></transaction-date>
   <value currency="USD" value-date="2020-03-29">14911</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-12626</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">12626</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">5925</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000950">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">394200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">432000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">163080</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004024">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-26"></transaction-date>
   <value currency="USD" value-date="2021-08-26">339120</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000951">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">628518</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">625148</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">93090</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004708">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">494340</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-soloman-islands-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Soloman Islands 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-soloman-islands-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Soloman Islands 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-solomon-islands-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Solomon Islands 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-solomon-islands-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Solomon Islands 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-solomon-islands-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Solomon Islands 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-solomon-islands-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Solomon Islands 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-solomon-islands-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Solomon Islands 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-solomon-islands-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Solomon Islands 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-07-27"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-SLB" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">World Bank : Programme Management - Financial Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(i) NUI AOP&amp;B for 2021 is linked to Provincial AOP&amp;B, and on-system and off-system contributions are included in the original MHMS budget.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Targeted support to build capacity for planning and budgeting, execution and oversight will assist MHMS to implement more effective vaccination programs that deliver the results expected. In addition, activities to support MHMS with its efforts to clarify roles and responsibilities between national and provincial programs will clearly benefit the EPI program. This includes improving quality of AOP&amp;B both at national and provincial levels (including supporting the AOP&amp;Bs with the gradual transition of Gavi on-system) and building capacity to shape stronger links between national and provincial AOP&amp;B and supporting provincial divisions to get resources to lower level facilities. In supporting MHMS track financing pressures to the health sector, provide TA and analytical assistance to update the Medium Term Expenditure Pressures Note. This will include supporting MHMS have a clearer picture of resource allocation and use across MHMS and the Provincial Divisions, including for the immunization program, to help support MHMS manage health financing pressures (including from Gavi transition) and inform annual AOP&amp;Bs.">
      <location ref="SB"></location>
     </target>
     <actual value="Completed">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">(i) Since the development of the National program AOP&amp;B, this has been subsequently shared with Provincial health teams. Provincial AOP&amp;B, after some delays have now been completed and submitted. There have been some linkages in activities but also some misalignments. These will continue to be progressed and improved through further communication with provinces.
(ii) Annual budget and expenditure trend analysis completed and shared with the MHMS and the MBC committee.
Also amending the costing report which has now received feedback from partners.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Targeted support to build capacity for planning and budgeting, execution and oversight will assist MHMS to implement more effective vaccination programs that deliver the results expected. In addition, activities to support MHMS with its efforts to clarify roles and responsibilities between national and provincial programs will clearly benefit the EPI program. This includes improving quality of AOP&amp;B both at national and provincial levels (including supporting the AOP&amp;Bs with the gradual transition of Gavi on-system) and building capacity to shape stronger links between national and provincial AOP&amp;B and supporting provincial divisions to get resources to lower level facilities. In supporting MHMS track financing pressures to the health sector, provide TA and analytical assistance to update the Medium Term Expenditure Pressures Note. This will include supporting MHMS have a clearer picture of resource allocation and use across MHMS and the Provincial Divisions, including for the immunization program, to help support MHMS manage health financing pressures (including from Gavi transition) and inform annual AOP&amp;Bs.">
      <location ref="SB"></location>
     </target>
     <actual value="Completed">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">(i) Since the development of the National program AOP&amp;B, this has been subsequently shared with Provincial health teams. Provincial AOP&amp;B, after some delays have now been completed and submitted. There have been some linkages in activities but also some misalignments. These will continue to be progressed and improved through further communication with provinces.
(ii) Annual budget and expenditure trend analysis completed and shared with the MHMS and the MBC committee.
Also amending the costing report which has now received feedback from partners.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Reports on national and subnational Rota vaccine data for vaccination coverage and related lessons learnt during introduction campaign.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="0">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">As part of the annual E-JRF reports, WHO continues to support MHMS to analyze Rotavirus vaccine coverage rates. The introduction of the Rotavirus vaccine in mid-2020 (June to September introduction across various Provinces) has an impact on the coverage rate in 2020, which assumes vaccination for the entire year. The E-JRF 2020 data shows Rotavirus vaccine coverage as 55% for 1st dose and 40% for 2nd dose. However, Monthly analysis across subnational coverage and considering roll-out timing illustrates a much higher coverage rate. WHO analysis indicates that true coverage is tracking well, between 70-90% coverage depending on Province and dose. As an Example, for a period of 12 months (May 2020 to May 2021) coverage for Western Province is 90% for 1st dose and 70% for 2nd dose. Attached coverage data illustrates Provincial breakdowns for both doses and further analysis is ongoing to investigate lowest coverage areas throughout the country.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="0">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">As part of the annual E-JRF reports, WHO continues to support MHMS to analyze Rotavirus vaccine coverage rates. The introduction of the Rotavirus vaccine in mid-2020 (June to September introduction across various Provinces) has an impact on the coverage rate in 2020, which assumes vaccination for the entire year. The E-JRF 2020 data shows Rotavirus vaccine coverage as 55% for 1st dose and 40% for 2nd dose. However, Monthly analysis across subnational coverage and considering roll-out timing illustrates a much higher coverage rate. WHO analysis indicates that true coverage is tracking well, between 70-90% coverage depending on Province and dose. As an Example, for a period of 12 months (May 2020 to May 2021) coverage for Western Province is 90% for 1st dose and 70% for 2nd dose. Attached coverage data illustrates Provincial breakdowns for both doses and further analysis is ongoing to investigate lowest coverage areas throughout the country.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Continue technical support fto the MHMS on timely EPI implementation, linkage an intergration within RMNCAH activities. Rota coverage report and RCM activities are taking place. JA submitted and reporting on GAVI portal for all technical activities in TCA.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support preparation and review of EPI programme with wide stakeholder consultation and input, prepare TORs related to incoming consultant for technical support. 
Coordinate the EPI review TA and support the linkage of the EPI review with historical review processes and future strategic planning and development of EPI Strategy for 2020-2025 and contribute to EPI priorities within the NHSP process. Solomon Islands Comprehensive Multi Year Plan (cMYP) draft initiated and consultation meetings supported. Technical support to the MHMS for Annual Operations activities planning and support on timely EPI implementation, linkage and intergration within RMNCAH programme and support coordination at the ICC/Family Health. Analytical assistance of DHIS2 data and data generated as part of MHMS review processes, the JRF data, JA document and new vaccine introductions. Support and technical advice for pandemic preparedness and surveillance activities.">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Technical support has been provided to the EPI unit in reviewing its current progress and planning for the next MHMS Annual Operations plan development. Whilst some routine EPI activities have been delayed due to covid and covid vaccines roll-out, some catch-u 
 activities and support for routine activities planning has been completed. Linkage with other RMNCAH programme has occurred through the ICC/Family Health Committee which has been supported to meet. Analytical assistance in terms of DHIS2 data and reviewing data trends / issues has been supported, including for new vaccines such as HPV, Rota and MR2nd dose. The JRF data has been reviewed and MHMS supported to utilize the new E-JRF portal. Rota coverage report is still to be supported, but planned for 3rd quarter. Completed reporting on GAVI portal for all technical activities in TCA</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support preparation and review of EPI programme with wide stakeholder consultation and input, prepare TORs related to incoming consultant for technical support. 
Coordinate the EPI review TA and support the linkage of the EPI review with historical review processes and future strategic planning and development of EPI Strategy for 2020-2025 and contribute to EPI priorities within the NHSP process. Solomon Islands Comprehensive Multi Year Plan (cMYP) draft initiated and consultation meetings supported. Technical support to the MHMS for Annual Operations activities planning and support on timely EPI implementation, linkage and intergration within RMNCAH programme and support coordination at the ICC/Family Health. Analytical assistance of DHIS2 data and data generated as part of MHMS review processes, the JRF data, JA document and new vaccine introductions. Support and technical advice for pandemic preparedness and surveillance activities.">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Technical support has been provided to the EPI unit in reviewing its current progress and planning for the next MHMS Annual Operations plan development. Whilst some routine EPI activities have been delayed due to covid and covid vaccines roll-out, some catch-u 
 activities and support for routine activities planning has been completed. Linkage with other RMNCAH programme has occurred through the ICC/Family Health Committee which has been supported to meet. Analytical assistance in terms of DHIS2 data and reviewing data trends / issues has been supported, including for new vaccines such as HPV, Rota and MR2nd dose. The JRF data has been reviewed and MHMS supported to utilize the new E-JRF portal. Rota coverage report is still to be supported, but planned for 3rd quarter. Completed reporting on GAVI portal for all technical activities in TCA</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">World Bank : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(i) National immunization program AOP&amp;B for 2021 is completed and is linked to Provincial AOP&amp;B and (ii) Complete provincial funding transition to on-system with initial review and analysis of budget and expenditure execution, inlcuding higlighting challenges and changes in financing flow and the impact on service delivery in the provinces (now having transitioned to on-system)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="(i) Continue to support MHMS with improving the quality of AOP&amp;B both at national and provincial levels and building capacity to shape stronger links between national and provincial AOP&amp;B for the budget process submission
(ii) Continue to support MHMS track financing pressures to the health sector, by updating the Medium Term Expenditure Pressures Note, and the budget and expenditure tracking analysis for MHMS (including for the immunization program) to have a clearer picture of resource allocation and use across MHMS, the national division and the Provincial Divisions
(iii) Continue to support the MHMS with the transition of the financing of the immunization program from off-system (outside government system) to on-system (using the government financial management system)
(iv) Continue with other partners to engage in dialogue/analysis with MHMS regarding the need and options for increased domestic financing in preparation for when the country graduates from GAVI financing in 2023">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">(i) AOP&amp;B for 2021 is completed. But support is now for the AOP&amp;B 2022 process which is to begin in July to feed into the Budget 2022 process
(ii) Continuing. There has been a delay in transition to on-system of remaining provinces. This is in progress.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(i) Annual Ministerial budget and expenditure and trend analysis (BETA) and the spending pressures note (MTEP) are completed and opportunities for more effective use of resources, and to inform planning and budget preparation processes within the Ministry; (ii) draft costing of EPI program to inform annual AOP&amp;B and budget submissions for 2022 including to inform the discussions around transition to domestic financing upon graduation</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="(i) Continue to support MHMS with improving the quality of AOP&amp;B both at national and provincial levels and building capacity to shape stronger links between national and provincial AOP&amp;B for the budget process submission
(ii) Continue to support MHMS track financing pressures to the health sector, by updating the Medium Term Expenditure Pressures Note, and the budget and expenditure tracking analysis for MHMS (including for the immunization program) to have a clearer picture of resource allocation and use across MHMS, the national division and the Provincial Divisions
(iii) Continue to support the MHMS with the transition of the financing of the immunization program from off-system (outside government system) to on-system (using the government financial management system)
(iv) Continue with other partners to engage in dialogue/analysis with MHMS regarding the need and options for increased domestic financing in preparation for when the country graduates from GAVI financing in 2023">
      <location ref="SB"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">BETA&amp;MTEP completed and shared with MHMS. Budget announcement 2022 was delayed from MOFT. EPI AOP&amp;B was completed and budget submission to MOFT done on October 29. However MOFT is yet to release budget for FY22. Parliament sitting to endorse budget in November was cancelled due to civil unrest. Budget execution case study underway with expected draft Q1 of 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Policy &amp; Regulatory Environment</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">i. Subject to MHMS prioritization the EPI team and Transition Plan are being utilized to leverage mutual beneficial changes for the programme and overall advancement of RDP, through health system building blocks alignment with EPI bottlenecks. ii. Family Health Committee (FHC) and MHMS /DP SWAp mechanism are utilized where possible&#xA0; for coordination of DP activities in implementation of Transition Plan, and more broadly alignment&#xA0; with MHMS policies.&#xA0; iii. Continued support to MHMS Executive in advocacy strategy through Solomon Islands Government budget process, for investments necessary for sustainable provision of EPI programme&#xA0; through and beyond transition plan.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide the overarching HSS capacity to support the MHMS in the MHMS/GAVI Transition Plan for a successful transition. In this multi year activity; MHMS executive team and Provincial Directors and management supported in restructure of service delivery platform in alignment with the Role DelinaeationPolicy. Linkages made between implementation bottlenecks across the HSS and CCEOP and with the MHSM broader reforms, and focus on strengthening integrated service delivery. Identification of governance mechanisms to improve fiscal allocations to the health sector. PCU or other MHMS mechanism supported to monitor relevant MHMS departments for Gavi Transition activities.">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">1.	During the reporting period, WHO provided technical assistance to Provinces for alignment with RDP. Through provincial visits, Provincial Health Authorities were supported to realign services in line with pandemic requirements and RDP. Technical visits took place to Malaita, Temotu and Choiseul Provinces. 
2.	Family Health Committee (FHC) remains main platform for coordination between partners and EPI is regularly part of the agenda. During 2021, three FHC meetings took place. 1) GAVI TCA was approved and recommended for endorsement to the executives; 2) Community Mobilization for EPI, WVI project progress and results in four provinces (Guadalcanal, Makira, Malaita, and Central Province) were presented on each meeting. The project aims to build the capacity of health care workers to implement EPI community mobilization. This is done through training and working with PHC Clinics Health Committees; 3) HPV immunization support through PATH was presented during Q2 meeting.
3.	As part of the Annual Operational Planning, MHMS organized National Health Conference, which was opportunity for broader programs realignment and detailed budgetary planning. The annual conference participants include key provincial health staff and Directors and Program Officers from MHMS. It provides opportunity for negotiation of health investments for the upcoming year at provincial and MHMS level.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">i. Following successful advocacy, relevant EPI programme recommendations are&#xA0; integrated in wider MHMS strategies through the NHSP 2021-25 &amp; DHS.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide the overarching HSS capacity to support the MHMS in the MHMS/GAVI Transition Plan for a successful transition. In this multi year activity; MHMS executive team and Provincial Directors and management supported in restructure of service delivery platform in alignment with the Role DelinaeationPolicy. Linkages made between implementation bottlenecks across the HSS and CCEOP and with the MHSM broader reforms, and focus on strengthening integrated service delivery. Identification of governance mechanisms to improve fiscal allocations to the health sector. PCU or other MHMS mechanism supported to monitor relevant MHMS departments for Gavi Transition activities.">
      <location ref="SB"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Delayed due to the new NHSP and Digital Health Strategy being still under development.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">i. Subject to MHMS prioritization the EPI team and Transition Plan are being utilized to leverage mutual beneficial changes for the programme and overall advancement of RDP, through health system building blocks alignment with EPI bottlenecks. 
ii. Family Health Committee (FHC) and MHMS /DP SWAp mechanism are utilized where possible&#xA0; for coordination of DP activities in implementation of Transition Plan, and more broadly alignment&#xA0; with MHMS policies.&#xA0; 
iii. Continued support to MHMS Executive in advocacy strategy through Solomon Islands Government budget process, for investments necessary for sustainable provision of EPI programme&#xA0; through and beyond transition plan.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide the overarching HSS capacity to support the MHMS in the MHMS/GAVI Transition Plan for a successful transition. In this multi year activity; MHMS executive team and Provincial Directors and management supported in restructure of service delivery platform in alignment with the Role DelinaeationPolicy. Linkages made between implementation bottlenecks across the HSS and CCEOP and with the MHSM broader reforms, and focus on strengthening integrated service delivery. Identification of governance mechanisms to improve fiscal allocations to the health sector. PCU or other MHMS mechanism supported to monitor relevant MHMS departments for Gavi Transition activities.">
      <location ref="SB"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">WHO Planned P5 Health Systems Coordinator position is currently under recruitment and near finalization. Following establishment in country, further work will continue on the restructuring of services in alignment with the Role Delineation Policy. However, WHO has SSA support working with MHMS Executive on RDP current evaluation and progress, with support given for Provincial visits and workshops. This will continue into the 3rd quarter and aim to also support Provinces in integrating service delivery during covid.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide the overarching HSS capacity to support the MHMS in the MHMS/GAVI Transition Plan for a successful transition. In this multi year activity; MHMS executive team and Provincial Directors and management supported in restructure of service delivery platform in alignment with the Role DelinaeationPolicy. Linkages made between implementation bottlenecks across the HSS and CCEOP and with the MHSM broader reforms, and focus on strengthening integrated service delivery. Identification of governance mechanisms to improve fiscal allocations to the health sector. PCU or other MHMS mechanism supported to monitor relevant MHMS departments for Gavi Transition activities.">
      <location ref="SB"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">WHO Planned P5 Health Systems Coordinator position is currently under recruitment and near finalization. Following establishment in country, further work will continue on the restructuring of services in alignment with the Role Delineation Policy. However, WHO has SSA support working with MHMS Executive on RDP current evaluation and progress, with support given for Provincial visits and workshops. This will continue into the 3rd quarter and aim to also support Provinces in integrating service delivery during covid.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Monthly and Quarterly reports will be available. Continuous support to the Surveillance Unit in the EPI unit by the SSA. Sentinel sites provided with staff trainings to support reporting and case diagnosis. Additional support for new AEFI reporting system and review DHIS2 new AEFI module data and follows-up.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthening VPDs? surveillance including case-based national surveillance with focus on acute flaccid paralysis (AFP) and acute fever and rash (AFR). SSA in country support and RO Staff travel (when required ) to provide technical support to the country for ongoing surveillance assessment, logistics for the lab testing of samples. Organize training for staff when needed. Coordinate with global and regional reference labs for results troubleshooting, interpretation, reconfirmation.">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">During the reporting period, WHO provided technical assistance for Hospital base active surveillance for Acute Flaccid Paralysis (AFP), Neonatal Tetanus (NNT) and Measles. Monthly reports are collected from the eight sentinel sites to assess and to monitor AFP, AFR and NNT occurrence in the health centres. Reference laboratory for AFP cases is the VIDRL, Melbourne and in 2021 all results are confirmed not to have enterovirus in the cell culture. Training for Sentinel site at NRH was organized earlier in 2021. Provincial Sentinel Officers were supported through weekly contacts to ensure issues concerning HBAS/VPD are well addressed and especially when there is an AFP case identified. Continuous dialogue with the officers helps to encourage them to do more on VPD surveillance. All officers are providing their monthly reports timely.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">In country SSA staff support for continued surveillance strengthening and RO Staff to provide technical support to the country (as needed) for ongoing surveillance assessments to strengthen reporting. Monthly surveillance report on AFP and AFR, supervision and training of the current sentinel sites. Support for new AEFI reporting systems and trainings.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthening VPDs? surveillance including case-based national surveillance with focus on acute flaccid paralysis (AFP) and acute fever and rash (AFR). SSA in country support and RO Staff travel (when required ) to provide technical support to the country for ongoing surveillance assessment, logistics for the lab testing of samples. Organize training for staff when needed. Coordinate with global and regional reference labs for results troubleshooting, interpretation, reconfirmation.">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">The WHO SSA for VPD is in place, as well as in-country Technical Officer and WPRO support for activities to strengthen VPD surveillance. At the planning level, the WPRO Regional Strategic Plan 2020-2030 (draft for RCM) has been utilized to identify key components of Solomons VPD Surveillance that need strengthening and these have been included in new cMYP Planning documents. At a practical implementation level, samples for AFR, AFP and NNT continue to be sent to VIDRL, with WHO providing logistical and coordination support for results troubleshooting, interpretation, and confirmation. Support was provided for set-up of the NRH Molecular Virology laboratory and enrolled in QA program and when quality is assured this capacity could have PCR testing expanded to include measles, rubella or Neonatal Tetnus, which would greatly reduce TAT for testing. HBAS is active in 8 provincial hospitals of the country (NRH, Gizo, Munda, Kilufi, Atoifi, Taro, KiraKira. ) Sentinel sites for Temotu has now been included following successful training, whilst Shortland Islands is pending set-up, requiring some infrastructure improvements and training on case definitions and reporting (training package and pre/post testing developed). Trainings have also been conducted for AEFI, with a new digital AEFI form and its inclusion in the COVAX roll-out in the new DHIS2 linking AEFI with individual patient records - something planned for expansion to routine EPI.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support provided to MHMS on integration plans</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MHMS to begin discussion of integration of HPV to routine activities of EPI, post-HPV dose 2">
      <location ref="SB"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Activity continues to be delayed as HPV activities are delayed in country and national level has not had time to monitor status of HPV dose 2 or the new cohort with the provinces or Honiara City Council (capital city). Efforts to secure local consultant before end of June have been unsuccessful. This activity will not be completed for this grant due to the ongoing disruption to immunization services due to covid control and covid vaccine rollout.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MHMS to begin discussion of integration of HPV to routine activities of EPI, post-HPV dose 2">
      <location ref="SB"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Activity continues to be delayed as HPV activities are delayed in country and national level has not had time to monitor status of HPV dose 2 or the new cohort with the provinces or Honiara City Council (capital city). Efforts to secure local consultant before end of June have been unsuccessful. This activity will not be completed for this grant due to the ongoing disruption to immunization services due to covid control and covid vaccine rollout.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MHMS to integrate HPV into routine activities of EPI, post-HPV dose 2 (2020)">
      <location ref="SB"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Activity continues to be delayed as HPV activities are delayed in country and national level has not had time to monitor status of HPV dose 2 or the new cohort with the provinces or Honiara City Council (capital city). Emails to the MHMS have not been responded to. WHO has been notified and indicated that the CHD director retired, leaving a leadership vacuum for EPI. Recent meeting with EPI and partners suggest some HPV vaccinations have restarted but deficiencies in HPV data recording limit our ability to determine if doses administered are HPV dose 2 for the MAC population from year 1 of national rollout or new HPV dose 1 for the next new cohort of 9 year olds. This activity will be incomplete during this grant period, but will be re-engaged in the new TA grant for the next time period.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Compilation of HPV dose 2 data completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support collation and analysis of monthly HPV vaccination coverage data after dose 2 (2020)">
      <location ref="SB"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Initial phone call to discuss HPV dose 2 with the country completed in June 2021. Discussions revealed that DHIS electronic system was not modified to capture HPV dose 2 data separately. This activity will not be completed in Exhibit 29. New efforts will be initiated for improving HPV data reporting in Exhibit 46.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NGO/CSO mapping developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide programme monitoring and technical assurance to the implementation of the CSO demand generation project in four provinces being implemented by World Vision">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Ongoing work with World Vision in 4 Provinces (Makira, Central Island, Malaita, Guadalcanal).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Update report with successes and lessons learnt</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Programme monitoring support for the effective implementation of the Gavi CSO grant for immunization demand generation activities in targeted communities.">
      <location ref="SB"></location>
     </target>
     <actual value="Completed">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">The Gavi CSO grant is progressing with UNICEF provided technical guidance and quality assurance through program monitoring visits. Our team continue to engage the CSO to guide effective implementation of the demand generation activties.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Programme monitoring support for the effective implementation of the Gavi CSO grant for immunization demand generation activities in targeted communities.">
      <location ref="SB"></location>
     </target>
     <actual value="Completed">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">The Gavi CSO grant is progressing with UNICEF provided technical guidance and quality assurance through program monitoring visits. Our team continue to engage the CSO to guide effective implementation of the demand generation activties.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Updated EPI comms strategy implementation plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Social mobilization for EPI covering (a) rotavirus introduction communication plan and materials (c) continued implementation of immunization and child health communication strategy">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">The Solomon Islands EPI communication strategy is being implemented with rollout targeting rotav vaccines and further strengthening routine immunization delivery, also piggy-backing COVID vaccination promotion as well.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Social mobilization for EPI covering (a) rotavirus introduction communication plan and materials (c) continued implementation of immunization and child health communication strategy">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">The Solomon Islands EPI communication strategy is being implemented with rollout targeting rotav vaccines and further strengthening routine immunization delivery, also piggy-backing COVID vaccination promotion as well.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Communication and social mobilization strategy developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Social mobilization for EPI covering (a) continued implementation of immunization and child health communication strategy (b) evaluate and update communication plan and materials to reflect additional pandemic response challenges">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">The update of the EPI communciation strategy is underway preceded by the review of status of implementation of the comms strategy (report attached). COVID response including vaccination has been intergated partly with the routine program communication.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support provided to MHMS on integration plans</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MHMS to integrate HPV into routine activities of EPI, post-HPV dose 2 (2020)">
      <location ref="SB"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Activity continues to be delayed as HPV activities are delayed in country and national level has not had time to monitor status of HPV dose 2 or the new cohort with the provinces or Honiara City Council (capital city). Emails to the MHMS have not been responded to. WHO has been notified and indicated that the CHD director retired, leaving a leadership vacuum for EPI. Recent meeting with EPI and partners suggest some HPV vaccinations have restarted but deficiencies in HPV data recording limit our ability to determine if doses administered are HPV dose 2 for the MAC population from year 1 of national rollout or new HPV dose 1 for the next new cohort of 9 year olds. This activity will be incomplete during this grant period, but will be re-engaged in the new TA grant for the next time period.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in initial dose 2 review meetings completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MHMS to monitor HPV dose 2 implemention progress, identify challenges, propose solutions (2020)">
      <location ref="SB"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Activity has been postponed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Review of HPV data improvements conducted with DHIS manager; plan for implementing improvements outlined</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Work with DHIS manager to improve data recording and reporting for HPV and other new vaccines">
      <location ref="SB"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Activity to be re-started in Q1 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Coverage improvement plans developed for identified low performing HPV areas or areas of vaccine hesitancy</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Work with low performing areas and/or areas of vaccine hesitancy in 2021 to develop coverage improvement plans for HPV, and in 2022 for all new vaccines (MSD, IPV, rota, in addition to HPV)">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Consultant held two meetings with HCC and several phone calls to GP provincial EPI coordinator. Initial discussions focused on the role of PATH in supporting MHMS with TA to provinces and clinics to get HPV vaccinations restarted.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">DHIS data of HPV reporting reviewed by province, zone, and facility</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitor progress of HPV vaccine rollout through data review in DHIS and direct follow up with provinces, zones, facilities">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Draft report of initial data review shared with MOH. Facilities divided into 8 groups based on whether HPV vaccines were delivered in 2019, 2020 and/or 2021. MHMS has not responded to request for DHIS data extraction of HPV vaccinations by month by facility for the three years. Reminders ongoing.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support to HCC provided and HPV vaccinations restarted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide direct support to HCC to restart HPV vaccinations (dose 2 MAC and dose 1 new cohort)">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Initial meetings have focused on just review of the data and situation today. Further direct support to map out solutions and then support to implement those solutions planned for Q1 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">No reporting or low performing facilities and zones identified from DHIS data review</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist with identification of low performing areas for HPV vaccines (in 2021) and other new vaccines introduced (MSD, IPV, rota) in 2022">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Initial review and conversation with EPI program about facilities vaccinating or not vaccinating for HPV resulted in prioritizing Honiara City Council (HCC) and Guadalcanal (GP) provinces in the first instance. Clinics that have not reported and those that did one round of vaccinations in 2019 at launch but no subsequent vaccinations will be focus of initial efforts to understand root causes of non-vaccination and brainstorming for actions to help improve HPV vaccination coverage.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Assistance provided to implement and monitor HPV, MSD and other recently new vaccines introduced</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to EPI coordinator for new vaccine introductions (HPV, MSD, IPV), with focus in 2021 on HPV and other new vaccines in 2022">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Local consultant has been hired. Two calls with MOH and EPI staff have re-affirmed the HPV TA activities for PATH. Local consultant has begun working at MHMS about once a week to assist with overall coordination and tracking of HPV activities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in JA completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in Gavi&apos;s annual Joint Appraisal and grant renewal processes to ensure continuity of HPV TA support">
      <location ref="SB"></location>
     </target>
     <actual value="Completed">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">PATH attended MSD dialogues from Nov. 2020 through April 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Mentoring and monitoring provided to areas implementing coverage improvement plans, using DHIS reported data review to track progress</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist with monitoring and mentoring activities with provinces/zones to implement coverage improvement plans for HPV (in 2021) or other new vaccine coverage (MSD, IPV, rota), with focus on those zero-dose or missing follow-up doses">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">To be started after the new year.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">% of target sites achieving readiness to receive cold chain (e.g. equipment on site, ready and w/ trained staff).</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate the implementation of EVM recommendations to improve the immunization and broader PHC supply chain; and implementation of the vaccine wastage reduction strategy through dedicated technical assistance">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Procurement and installation of additional cold chain equipment at central vaccines stores, provinces and health facilities is ongoing (ultra cold chain equipment for Pfizer vaccines, standby generator for the national vaccine stores, 100 solar driven refrigerators0.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Quarterly reporting of subnational stock data from at least 3 provinces available.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Immunization supply chain strengthening through (a) strengthening subnational stock management (b) facilitate incorporation of VVM and vaccine wastage data into Msupply (c) explore vaccine waste management plan for 2 provinces (d) implementing action points from the vaccine wastage reduction strategy (e) post-installation inspection (PII) for installed equipment under the CCEOP, and (f) comprehensive cold chain inventory assessment reflecting the newly installed cold chain equipmen">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Quarterly reporting of subnational stock received from 6 second level medical stores by March 2021. A consultant recruitment ongoing to further implemented specific vaccine management strengthening items.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Immunization supply chain strengthening through (a) strengthening subnational stock management (b) facilitate incorporation of VVM and vaccine wastage data into Msupply (c) explore vaccine waste management plan for 2 provinces (d) implementing action points from the vaccine wastage reduction strategy (e) post-installation inspection (PII) for installed equipment under the CCEOP, and (f) comprehensive cold chain inventory assessment reflecting the newly installed cold chain equipmen">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Quarterly reporting of subnational stock received from 6 second level medical stores by March 2021. A consultant recruitment ongoing to further implemented specific vaccine management strengthening items.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Roadmap for improved integration of EPI with other PHC services</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist the MHMS and EPi program to udate the routne immuniztaion microplans, strengthening routine immunization outreaches and supervision with broader integration of PHC services">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Supported microplanning for COVID-19 vaccination integrated with routine immunisation in 3 provinces (Honiara City Council, Guadalcanal and Malaita).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery related barriers of missed communities to access immunisation services identified and prioritized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance and accompaniment provided to MHMS on; sustainable EPI programme management and implementation, EVM implementation, HSS &amp; vaccine renewal requests and reporting, Multistakeholder dialogue updates to facilitate the transition process from Gavi, and vaccines security for the EPI program in view of the COVID-19 pandemic.">
      <location ref="SB"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Technical assistance and inputs for vaccine renewal requests, HSS renewal requests, and multistakeholder dialogues. Due to additional pressure on the MHMS, submission was delayed. However, the vaccine renewal request is completed and submitted.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance and accompaniment provided to MHMS on; sustainable EPI programme management and implementation, EVM implementation, HSS &amp; vaccine renewal requests and reporting, Multistakeholder dialogue updates to facilitate the transition process from Gavi, and vaccines security for the EPI program in view of the COVID-19 pandemic.">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Technical support is ongoing for routine catch up immunisation, sustained vaccine supplies and community mobilisation. Preparations are ongoing for MSD in December 2021 and EVM Assessment in 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Vaccines security strengthened with timely forecast completed and submitted.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance and accompaniment provided to MHMS on; EPI programme management and implementation, Rotavirus vaccine introduction, EVM implementation, HSS &amp; vaccine renewal requests, Joint appraisal updates to facilitate the transition process from Gavi, and vaccines security for the EPI program.">
      <location ref="SB"></location>
     </target>
     <actual value="Completed">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Technical assistance being provided to strengthen vaccine security and forecast. The 2021 vaccine forecast for the MHMS was completed on schedule. Inputs were also provided for the vaccine renewal requests to Gavi and continued implementation of EVM recommendations. Plans to have an ISC consultant delayed due to travel restrictions but process underway. Despite travel challenges, Solomon Islands mainatins uninterrupted vaccines and supplies stock with no stockouts reported.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance and accompaniment provided to MHMS on; EPI programme management and implementation, Rotavirus vaccine introduction, EVM implementation, HSS &amp; vaccine renewal requests, Joint appraisal updates to facilitate the transition process from Gavi, and vaccines security for the EPI program.">
      <location ref="SB"></location>
     </target>
     <actual value="Completed">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Technical assistance being provided to strengthen vaccine security and forecast. The 2021 vaccine forecast for the MHMS was completed on schedule. Inputs were also provided for the vaccine renewal requests to Gavi and continued implementation of EVM recommendations. Plans to have an ISC consultant delayed due to travel restrictions but process underway. Despite travel challenges, Solomon Islands mainatins uninterrupted vaccines and supplies stock with no stockouts reported.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Based on MHMS prioritization, the EPI Team will use the Transition Plan to leverage resources necessary to bring about changes that benifit the Programme and enhance the overall advancement of RDP. Guided by the system building blocks alignment with All activies require to minimize EPI bottlenecks will be alligned with the System Building Blocks.. 
2) Support the development and advancement of further integrated frameworks and systems that can help the Program to: measure progress and meaningfully inform the pursuit of national health and development goals; focus on the generation, analysis and use of metrics that are relevant to policy-makin; and guide implementation and resource allocation at all levels, Collecting EPI. Disaggregated data will also be essential to determinr where health inequities exist and to address health issues in an equitable manner.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Manage and lead the health systems strengthening interventions related to policy development provision of advisory services to the MHMS and other ministries of Solomon Islands;
2) Support the MHMS to use the recommendations included in the review report of the 2015-2021 to inform the development and finalize a new NHSP for 2022-2026;
3) Support the MHMs develop a national digital health strategy emphasizing Immunization related activities particularly those regarding data collection and sharing on immunization target groups, reporting and notification. 
4) Enhance cooperation within MHMS and among health Departments and Units especially the Surveillance and EPI Units. 
5) Ensure that immunization key activities and aspects are well presented and prioritized in the new NHSP and that they are in line with Role Delineation Policy (RDP) and comply with its Service Delivery Packages standards; and
6) Support the development and implementation of the Government?s pandemic preparedness and response plan at different strategic levels with accent on immunization and provide all type of technical required to implement the GAVI HSS Grant.">
      <location ref="SB"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">1. WHO led health systems strengthening interventions mainly focusing on development of the new National Health Strategic Plan (NHSP) 2022-2026 and Digital Health Strategic Plan (DHSP). 
WHO supported MHMS in developing next NHSP, by engaging a consulting company with various types of expertise that would be working online and will be supported by the Ministry and local team. The approach for the development of NHSP includes: inception and planning; situational analysis; stakeholder consultation; drafting NHSP; sensemaking workshops and final draft of NHSP. The work started in November 2021, with an inception meeting between WHO, MHMS, and the consultants. The discussions involved background, Objectives, and guidance to new NHSP; expectations, formulation, and process of the new NHSP and scope of Work, deliverables and timelines also Mitigations and Governance. WHO will provide technical support and expertise from Regional Office as needed. 
2. During the reporting period, WHO provided technical assistance to MHMS in developing Digital Health Strategic Plan (DHSP). Series of consultations were organized with the Digital Health Steering Committee and MHMS executives to guide the process further. The Strategy looks into developments of the digital infrastructure in the country and advancing further digital health. The proposals include possible introduction of patient unique ID number as well as digitalization of health services. The process will continue into 2022. Health system digitalization is considered as important in light of obtaining disaggregated data, understanding health inequities and inequities and designing adequate measures.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Following successful development of the new NHSP, advocacy for having relevant EPI programme recommendations integrated in wider MHMS strategies including the NHSP 2022-26 &amp; Digital Health Strategy.. 2) Following advocacy and guidance MHMS, Executives adopt a Strategic Framework to guide the implementation of activiyties needed to meet the short, medium and long term objectives of the Role Delineation Policy ? and highlight the activities included in health system building blocks as priorities for MHMS AOP planning. The Strategic Framework will include the attributes of the health system needed to determine country path to achieving UHC (i.e. ensuring that short-term actions lead to building robust health systems that provide comprehensive coverage of EPI and other services).</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Manage and lead the health systems strengthening interventions related to policy development provision of advisory services to the MHMS and other ministries of Solomon Islands; 2) Support the MHMS to use the recommendations included in the review report of the 2015-2021 to inform the development and finalize a new NHSP for 2022-2026; 3) Support the MHMs develop a national digital health strategy emphasizing Immunization related activities particularly those regarding data collection and sharing on immunization target groups, reporting and notification. 4) Enhance cooperation within MHMS and among health Departments and Units especially the Surveillance and EPI Units. 5) Ensure that immunization key activities and aspects are well presented and prioritized in the new NHSP and that they are in line with Role Delineation Policy (RDP) and comply with its Service Delivery Packages standards; and 6) Support the development and implementation of the Government?s pandemic preparedness and response plan at different strategic levels with accent on immunization and provide all type of technical required to implement the GAVI HSS Grant.">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">1.	In the reporting period WHO led the process for development of the new strategic documents i.e. NHSP and Digital Health Strategic Plan. In the ongoing process for its development, WHO ensures that key components of the health system are reflected, and EPI program recommendations are integrated. The next NHSP builds on the achievements of the previous Strategic Plan and aims to contribute to achieving Universal Health Coverage. The new NHSP is to be completed by March 2022. WHO ensures that the process of development of strategic documents is inclusive of stakeholders participation and is guided and led my MHMS. 
2.	As part of the Annual Operational Planning, MHMS organized National Health Conference, which was opportunity for broader programs realignment and detailed budgetary planning. The annual conference participants include key provincial health staff and Directors and Program Officers from MHMS. It provides opportunity for negotiation of health investments for the upcoming year at provincial and MHMS level.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Coordination and management of COVAX related technical support from WHO country TA, DPS and RO. Linkage and intergration with COVAX activities that can be leveraged for routine immunization - specifically the proposed DHIS2 tracker module and its roll-out.Technical support provided to the EPI review process, continue to develop linkages to EPI Regional strategic plan (WHO and GVAP), support finalization of the draft cMYP (Comprehensive Multi-Year Plan) 2021-2025</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support in finalizing draft cMYP with MHMS and partners - linkages to EPI Regional strategic plan (WHO and GVAP), consultant planning and technical support to the MHMS for Annual Operations activities planning. Support linkage and intergration within DHIS2 and new tracker module for COVAX, expanded to other vaccines, with capacity building for more advanced data analysis and data sharing between platforms ? resulting in improved quality and timely information for decision making. Support new vaccine introduction, including support to IPV second dose and continued strenghtening of HPV, Rota and MR second dose.">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">The WHO Solomon Islands EPI Technical Officer continued to support the country Immunization programme in a range of strategic areas, including to review the Regional Vaccine Preventable Diseases Strategic Framework and utilize the strategic areas for the new Solomons cMYP. In support of COVAX, the EPI Officer also supported Vaccine Roll-out planning and readiness, with TWG and NCC set-up and the COVAX applications and NVDP being completed. supported development of training packages and trainings of staff for vaccine deployment . A key focus has been on working with Oslo University and the HIS team to set-up a new server and DHIS tracking module for Covid Vaccines. Following numerous trainings this system is fully set-up and running and will look to be implemented in routine vaccine data collection for EPI, in a phased approach, potentially starting with HPV. Surveillance and Laboratory strengthening activities were continued, and specifically the review and setup of the MHMS new qPCR molecular testing laboratory, which will be beneficial in developing improved VPD surveillance capacity in the future. Continued support to the MHMS was provided to ensure routine EPI activities were maintained during COVID-19 and planning for better integration within RMNCAH activities, including for the development of the 2021 AOP. Reports on the progress on TCA activities conducted have been reported on the portal. Although COVID-19 has delayed the first steps of the EPI Review (situation analysis, objectives and milestones, strategies and activities, data collection and analysis) were delayed, there was significant contribution to the development of the draft 2021-25 Solomon Islands Comprehensive Multi Year Plan (cMYP) which is ready for consultation with MHMS and stakeholders.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Following successful development of the new NHSP, advocacy for having relevant EPI programme recommendations integrated in wider MHMS strategies including the NHSP 2022-26 &amp; Digital Health Strategy..
2) Following advocacy and guidance MHMS, Executives adopt a Strategic Framework to guide the implementation of activiyties needed to meet the short, medium and long term objectives of the Role Delineation Policy ? and highlight the activities included in health system building blocks as priorities for MHMS AOP planning. The Strategic Framework will include the attributes of the health system needed to determine country path to achieving UHC (i.e. ensuring that short-term actions lead to building robust health systems that provide comprehensive coverage of EPI and other services).</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Manage and lead the health systems strengthening interventions related to policy development provision of advisory services to the MHMS and other ministries of Solomon Islands;
2) Support the MHMS to use the recommendations included in the review report of the 2015-2021 to inform the development and finalize a new NHSP for 2022-2026;
3) Support the MHMs develop a national digital health strategy emphasizing Immunization related activities particularly those regarding data collection and sharing on immunization target groups, reporting and notification. 
4) Enhance cooperation within MHMS and among health Departments and Units especially the Surveillance and EPI Units. 
5) Ensure that immunization key activities and aspects are well presented and prioritized in the new NHSP and that they are in line with Role Delineation Policy (RDP) and comply with its Service Delivery Packages standards; and
6) Support the development and implementation of the Government?s pandemic preparedness and response plan at different strategic levels with accent on immunization and provide all type of technical required to implement the GAVI HSS Grant.">
      <location ref="SB"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">The current NHSP has been extended to 2021 and the new NHSP will thus be developed for 2022-2026. Currently, the 2016-2020 NHSP has been reviewed by a team of experts that WHO have procured and as part of the process have reviewed key strategic health documents, including the GAVI Transition Plan and EPI reports among other reports and documents. The review team have conducted in depth interviews with MHMS Executives, division and provincial directors, beneficiaries and other stakeholders to document best practices and lessons learned and advise the development of the 2022-2026 NHSP. WHO is currently recruiting the consultation TA to develop the new NHSP in 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support for strengthening VPD surveillance and laboratory diagnostics. Molecular laboratory capacity built for conducting range of VPD diagnostics.
Countries cMYP 2021-25 submitted for endorsement</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support in finalizing draft cMYP with MHMS and partners - linkages to EPI Regional strategic plan (WHO and GVAP), consultant planning and technical support to the MHMS for Annual Operations activities planning. Support linkage and intergration within DHIS2 and new tracker module for COVAX, expanded to other vaccines, with capacity building for more advanced data analysis and data sharing between platforms ? resulting in improved quality and timely information for decision making. Support new vaccine introduction, including support to IPV second dose and continued strenghtening of HPV, Rota and MR second dose.">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">The finalization of the cMYP is to be complited at the beginning of 2022. WHO supports EPI team in data analysis and development of catch up and mop-campaigns for routine immunization. Honiara City Council implemented the catchup campaign in November 2021, with the other provinces to follow early 2022. New tracker module for COVAX is in place and is a main resource for COVID19 immunization coverage updates. Further work is required to integrate other vaccines. National Laboratory was strengthen to conduct range of VPD molecular testing.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Monthly and Quarterly reports will be available. Continuous support to the Surveillance Unit in the EPI unit by the SSA, and the RO. Sentinel sites expanded with staff trainngs to support.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthening VPDs? surveillance including case-based national surveillance with focus on acute flaccid paralysis (AFP) and acute fever and rash (AFR). SSA in country support and RO Staff travel (when required ) to provide technical support to the country for ongoing surveillance assessment, logistics for the lab testing of samples. Organize training for staff when needed. Coordinate with global and regional reference labs for results troubleshooting, interpretation, reconfirmation. Expand sentinel sites to 1 low performing zone (Guadalcanal) and 1 border site in proximity to PNG.">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Vaccine Preventable Disease surveillance and other safety surveillance monitoring are key pillars within the Immunization programme that WHO has been supporting in Solomon Islands. Although there have been gaps within reporting and HR constrains, the VPD Surveillance HBAS network has 8 sites that are functional, with all monitoring AFR, AFP and NNT. WHO has supported trainings and workshops on VPD surveillance as well as participation in a regional workshop for AEFI reporting and surveillance monitoring, training national and provincial counterparts. WHO has supported sample logistics and testing and building of networks for laboratory testing given the constrains of COVID-19. The MHMS was supported to initiate a new molecular laboratory with qPCR capacity, with the EPI Technical Officer supporting the laboratory assessment, redesign, training and SOPs (attached report). In the future this molecular testing capacity could enable testing for some VPDs in country to rapidly diagnose, before confirmatory testing at a Reference laboratory - this was discussed at the recent TAG30 meeting with WPRO. New RDT diagnostics are also under consideration. Furthermore WHO continues to support a VPD surveillance SSA position, with monthly reports from all sites being submitted and support for following up on AFR/AFP samples being sent to Australia for testing.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthening VPDs? surveillance including case-based national surveillance with focus on acute flaccid paralysis (AFP) and acute fever and rash (AFR). SSA in country support and RO Staff travel (when required ) to provide technical support to the country for ongoing surveillance assessment, logistics for the lab testing of samples. Organize training for staff when needed. Coordinate with global and regional reference labs for results troubleshooting, interpretation, reconfirmation. Expand sentinel sites to 1 low performing zone (Guadalcanal) and 1 border site in proximity to PNG.">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Vaccine Preventable Disease surveillance and other safety surveillance monitoring are key pillars within the Immunization programme that WHO has been supporting in Solomon Islands. Although there have been gaps within reporting and HR constrains, the VPD Surveillance HBAS network has 8 sites that are functional, with all monitoring AFR, AFP and NNT. WHO has supported trainings and workshops on VPD surveillance as well as participation in a regional workshop for AEFI reporting and surveillance monitoring, training national and provincial counterparts. WHO has supported sample logistics and testing and building of networks for laboratory testing given the constrains of COVID-19. The MHMS was supported to initiate a new molecular laboratory with qPCR capacity, with the EPI Technical Officer supporting the laboratory assessment, redesign, training and SOPs (attached report). In the future this molecular testing capacity could enable testing for some VPDs in country to rapidly diagnose, before confirmatory testing at a Reference laboratory - this was discussed at the recent TAG30 meeting with WPRO. New RDT diagnostics are also under consideration. Furthermore WHO continues to support a VPD surveillance SSA position, with monthly reports from all sites being submitted and support for following up on AFR/AFP samples being sent to Australia for testing.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EPI and RMNCAH data collection is integrated into HIS of the MHMS according to the Digital Health Strategy. Mobile data collection piloted. Initial reports generated.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical Assistance provided to support MHMS Health Information Systems, with the goal of sustaining past gains and to further strengthen the national HIS, including the development of digital health strategy&gt; This will include capacity building for more advanced data analysis and data sharing between platforms ? resulting in improved quality and timely information for decision making. Support will include complementary initiatives to improve EPI case based information.">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Whilst significant support has focused on the Digital Health capacity requirements for COVAX and the new DHIS2 dashboard for Covid vaccines, work has progressed on HIS for routine EPI and in the Digital Health Strategy space. A Digital Health Strategy has been drafted with significant inputs from the EPI programme and the EPI WHO Technical Officer. The consultancy firm NEM will present to the MHMS shortly and then hold final consultation workshops for the strategy with wider MHMS stakeholders. Much consideration has been given to the various data platforms MHMS will be using and in linking these systems. WHO has also completed a consultancy to review the data system needs for vaccines and produce a data framework model. Through the DHIS work on COVAX, mobile data platforms and reporting are undergoing setup and will be piloted in June/July.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical Assistance provided to support MHMS Health Information Systems, with the goal of sustaining past gains and to further strengthen the national HIS, including the development of digital health strategy&gt; This will include capacity building for more advanced data analysis and data sharing between platforms ? resulting in improved quality and timely information for decision making. Support will include complementary initiatives to improve EPI case based information.">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Whilst significant support has focused on the Digital Health capacity requirements for COVAX and the new DHIS2 dashboard for Covid vaccines, work has progressed on HIS for routine EPI and in the Digital Health Strategy space. A Digital Health Strategy has been drafted with significant inputs from the EPI programme and the EPI WHO Technical Officer. The consultancy firm NEM will present to the MHMS shortly and then hold final consultation workshops for the strategy with wider MHMS stakeholders. Much consideration has been given to the various data platforms MHMS will be using and in linking these systems. WHO has also completed a consultancy to review the data system needs for vaccines and produce a data framework model. Through the DHIS work on COVAX, mobile data platforms and reporting are undergoing setup and will be piloted in June/July.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">i. A plan is developed and process in place for the MHMS Executive to lead the review of National Health Strategic Plan (NHSP) for 2021-25 The Drafting of NHSP 2021-25 is underway with EPI programme and transition plan appropriately reflected.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide the overarching HSS capacity to support the MHMS in the MHMS/GAVI Transition Plan for a successful transition. In this multi year activity; MHMS executive team and Provincial Directors and management supported in restructure of service delivery platform in alignment with the Role DelinaeationPolicy. Linkages made between implementation bottlenecks across the HSS and CCEOP and with the MHSM broader reforms, and focus on strengthening integrated service delivery. Identification of governance mechanisms to improve fiscal allocations to the health sector. PCU or other MHMS mechanism supported to monitor relevant MHMS departments for Gavi Transition activities.">
      <location ref="SB"></location>
     </target>
     <actual value="On Track">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Although a longer process than initially anticipated, the NHSP for 2022-26 is on track now, with the review steps complete and report submitted to MHMS for endorsement. The next stage will be lead by MHMS Executive group and a consultant firm that are currently under recruitment by WHO. Applications have been received and a shortlist of candidates shared with MHMS.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Contingent upon PS appointment and decision around pace and sequencing of MHMS reforms; RO participation in MHMS strategy development for sustainable fiscal allocations for health sector and EPI programme.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. TA support for HSS from WHO Regional Office providing a) Integrating immunization financing, planning and/or budgeting into national systems, to ensure sustainability of immunization coverage post-Gavi. b) Mobilizing domestic resources for health, to e">
      <location ref="SB"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">Due to a focus on the highest level strategic health priorities (such as the currently ongoing NHSP and Digital Health strategy) and since the MHMS financing TA position is vacant (but recruitment in process with DFAT support), the work on sustainable financing has been delayed until the WHO P5 HSS Coordinator recruitment is finalized.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">MHMS supported in development and adoption of strategy for sustainable fiscal allocations to health sector and EPI. PCU or other MHMS mechanism supported to monitor relevant MHMS&#xA0;Gavi Transition activities.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide the overarching HSS capacity to support the MHMS in the MHMS/GAVI Transition Plan for a successful transition. In this multi year activity; MHMS executive team and Provincial Directors and management supported in restructure of service delivery platform in alignment with the Role DelinaeationPolicy. Linkages made between implementation bottlenecks across the HSS and CCEOP and with the MHSM broader reforms, and focus on strengthening integrated service delivery. Identification of governance mechanisms to improve fiscal allocations to the health sector.&#xA0;PCU or other MHMS mechanism supported&#xA0;to monitor relevant MHMS departments for Gavi Transition activities.">
      <location ref="SB"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SB"></location>
      <comment>
       <narrative xml:lang="EN">in early 2021, WHO has now gained agreement from MHMS and has advertised the P5 Health Systems Coordinator Position, with recruitment ongoing, which will focus on the deliverables related to: Supporting the MHMS in the MHMS/GAVI Transition Plan for a successful transition, Restructure of service delivery platform in alignment with the Role Delinaeation Policy, Linkages made between implementation bottlenecks across the HSS and in Sustainable financing. During this process of recruitment, A health systems short term consultant TA has been in place, however, due to COVID-19 response and preparations activities and the resources required to build capacity in this area, WHO agreed with GAVI to repurpose some TA support to MHMS for this. TA support for the HSS role, was at the request of MHMS, repurposed to strengthen the provision of timely updates on the pandemic situation to help the COVID-19 Management taskforce to take informed decisions; work closely with the Undersecretary of Public Health to oversee the implementation of activities carried out by the National Health Emergency Operation Center (NHEOC), including disease surveillance, stockpiling essential medical supplies, COVID-19 case management and IEC activities; Assist the essential Divisions such as Health Promotion to ensure that advisories, quarantine and isolation, key messages to the public and media are consistent and scientifically sound; and to strengthen the coordination among various sectors to ensure that WHO guidelines and protocols are strictly followed. Furthermore, much of the broader Health System Reform Agenda was postponed, with the NHSP review commenced only in the second half of 2020 and to be finalized in 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned)
6. LMIS digital package installed
7. Birth notifiation digital package installed
8. Scorecard app installed
9. BNA app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="SB"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SB"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. EPI digital package installed
2. Data quality app installed
3. EPI legacy data migrated
4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="SB"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SB"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned) 6. LMIS digital package installed 7. Birth notifiation digital package installed 8. Scorecard app installed 9. BNA app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="SB"></location>
     </target>
     <actual>
      <location ref="SB"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on planned digital data package or app and know how to use it
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="SB"></location>
     </target>
     <actual>
      <location ref="SB"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. EPI digital package installed 2. Data quality app installed 3. EPI legacy data migrated 4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="SB"></location>
     </target>
     <actual>
      <location ref="SB"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Transition plan for EPI in place with agreed date for end of parallel system
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="SB"></location>
     </target>
     <actual>
      <location ref="SB"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
